A Mobile Application Based Dietary Self Management Intervention in Chinese

Status Not yet recruiting

Clinical Trial Summary

This is a multi-center randomized controlled study. This study aims to investigate the acceptability and efficacy of a newly developed mobile application in the dietary management of chronic kidney disease (CKD) patients.

Clinical Trial Description

The prevalence of CKD has reached 10.8% in China. Increasing in prevalence of other non-communicable disease such as hypertension, diabetes and obesity is contributing to this rise in CKD and end-stage renal disease prevalence. Diet is a strong modifiable factor in these diseases. Dietary control is also an integral part in CKD disease self management. However, the complexity in the dietary management of CKD makes it hard for patients to adequately self manage. With the development of smart phone, many mobile applications have been developed to suit the need of patients with chronic diseases. But there has been a scarce of randomized trial to support the feasibility, acceptability and efficacy of these mobile applications. Our study aims to employ a newly developed dietary logging and monitoring application in the primary care setting of CKD patients to test its acceptability and efficacy in disease control. The application is developed by a multidisciplinary team in a tertiary care center. The main features include searching and logging foods, receiving realtime feedback on key nutrient intake levels and facilitating patient-care giving communication. We plan to enroll 14 tertiary hospitals and 42 secondary hospitals in 7 geographical regions in China aiming to reach participants in resource poor areas. Participants will be randomized with 1 to 1 ratio to either receiving mobile application dietary intervention or usual dietary consultation. The planned intervention period is 3 months. We will monitor biochemical parameters relating to dietary control and evaluate patient-centered outcomes concerning CKD self management and control. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04940819
Study type	Interventional
Source	Peking Union Medical College Hospital
Contact	Xixi Zheng, MD
Phone	+8613521145030
Email	zxxpumch@163.com
Status	Not yet recruiting
Phase	N/A
Start date	June 2021
Completion date	June 2023

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT01155128` - Effects of an Exercise Program in Patients With Hypertensive Chronic Kidney Disease	Phase 4
Completed	`NCT00962000` - Study of How the Dose of Dialysis is Affected by Dialysate Flow Rate	N/A
Completed	`NCT00560014` - Nutrient Levels Alter Transplant Outcome	N/A
Completed	`NCT03274921` - Biomarkers of Cardiovascular Complications in Chronic Kidney Disease
Completed	`NCT01964014` - Once-a-day Immunosuppression(CISECON_a_day)	Phase 4
Recruiting	`NCT01728415` - Effects of High-intensity Interval Training in Patients in Hemodialysis	N/A
Completed	`NCT01532297` - Application of Citrate Dialysate in Chronic Haemodialysis	N/A
Completed	`NCT04100551` - Relationship Between Chronic Renal Disease and Risk Stratification for Chronic Ulcer on the on the Diabetic Foot
Recruiting	`NCT04428827` - Outcome of Patients With Primary Aldosteronism
Completed	`NCT02299661` - Pilot PK/PD Study of DS-1093a in Patients With Chronic Kidney Disease	Phase 1
Recruiting	`NCT02190318` - Residual Renal Function Preservation in Peritoneal Dialysis Patients	N/A
Terminated	`NCT01402219` - Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients	Phase 4
Not yet recruiting	`NCT04157647` - Hemadsorption During and After Cardiopulmonary Bypass to Modulate the Inflammatory Response	N/A
Completed	`NCT04897672` - 2D-speckle Tracking in Pediatric Renal Chronic Disease
Terminated	`NCT02375711` - Immunosenescence and Hepatitis B Virus (HBV) Vaccine Efficacy in Chronic Renal Disease Patient	N/A
Completed	`NCT01817322` - Kidney Graft Function Under the Immunosuppression Strategies	Phase 4
Completed	`NCT05383261` - The Impact of the Social Factors and Rehabilitation Program to Address the Implications on Kidney Failure in Hail
Completed	`NCT02834026` - Impact of the Cycle Ergometer in Muscle Strength and Pulmonary Function in Patients in Hemodialysis	N/A
Completed	`NCT02072837` - Dyslipidemia-related Risk Factors in Dialysis	N/A
Recruiting	`NCT03425708` - Effect of Hyperuricaemia on Chronic Renal Disease	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Mobile Application Based Dietary Self Management Intervention in Chinese Chronic Kidney Disease Patients — CRISS-MADE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms